SPRY

ARS Pharmaceuticals, Inc. - Common Stock (SPRY)

About ARS Pharmaceuticals, Inc. - Common Stock (SPRY)

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

Details

Daily high

$15.44

Daily low

$14.32

Price at open

$15.25

52 Week High

$18.51

52 Week Low

$7.55

Market cap

1.5B

Dividend yield

0.00%

Volume

1.1M

Avg. volume

1.9M

P/E ratio

195.57

ARS Pharmaceuticals, Inc. - Common Stock News